Tag: markets

Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

BRIDGEWATER, N.J., June 14, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced first clinical proof-of-concept data for LB2501, its investigational in vivo CD19/CD20 dual-targeting CAR-T cell therapy, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (R/R B-NHL). The results are being presented today in a late-breaking session at the European Hematology Association (EHA) 2026 Congress (Abstract #LB5006).

TAIWAN DESIGN POWER Debuts at Busan Design Festival, Showcasing Taiwan’s Design Innovation and Creative Value

The "TAIWAN DESIGN POWER" Taiwan Pavilion, showcased at the Busan Design Festival in South Korea, brings together 25 design projects and 20 industry representatives, demonstrating...

Futu Investor News: If You Have Suffered Losses in Futu Holdings Limited (NASDAQ: FUTU), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, June 13, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Futu Holdings Limited (NASDAQ: FUTU) resulting from allegations that Futu may have issued materially misleading business information to the investing public.

XM Announces Enhanced Trading Conditions and Opportunities for Global Traders – Featuring Partner Code 274PQ

TORONTO, June 14, 2026 (GLOBE NEWSWIRE) -- As participation in online financial markets continues to expand worldwide, trading platforms are increasingly focused on technology, education, and user accessibility. XM, an international online trading platform, has announced ongoing developments across its platform ecosystem while highlighting the availability of Partner Code 274PQ for eligible new users during the registration process.

Nalvurikenz Officially Launches Its Advanced AI Trading Platform for the Next Generation of Intelligent Investing in 2026

New York City, June 13, 2026 (GLOBE NEWSWIRE) --

In 2026, Nalvurikenz officially announced the release of its new AI-powered trading platform, integrating unique features and functionalities to simplify the trading process using a combination of artificial intelligence, live data analytics, and advanced automation.

Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Media Release

COPENHAGEN, Denmark; June 13, 2026

TTW Announces Top 50 Amusement Park Travel Destinations in the World for 2026

NEW YORK, June 13, 2026 /PRNewswire/ -- Travel And Tour World (TTW) today announced its Top 50 Amusement Park Travel Destinations in the World...

Ripple’s XRP Meets AI Trading: AIXAlpha Launches Free AI Strategy Contracts with Daily Settlement

Join XRP and top assets through AI-driven automated strategies with daily settlement—no manual trading needed.

Join XRP and top assets through AI-driven automated strategies with daily settlement—no manual trading needed.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsMarkets

Lilly’s Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with...

Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

TAIWAN DESIGN POWER Debuts at Busan Design Festival, Showcasing Taiwan’s Design Innovation and Creative Value

Tag: markets

Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

TAIWAN DESIGN POWER Debuts at Busan Design Festival, Showcasing Taiwan’s Design Innovation and Creative Value

Futu Investor News: If You Have Suffered Losses in Futu Holdings Limited (NASDAQ: FUTU), You Are Encouraged to Contact The Rosen Law Firm About...

XM Announces Enhanced Trading Conditions and Opportunities for Global Traders – Featuring Partner Code 274PQ

Nalvurikenz Officially Launches Its Advanced AI Trading Platform for the Next Generation of Intelligent Investing in 2026

Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

TTW Announces Top 50 Amusement Park Travel Destinations in the World for 2026

Ripple’s XRP Meets AI Trading: AIXAlpha Launches Free AI Strategy Contracts with Daily Settlement

FREELANDER 8 Makes First Public Appearance Ahead of Official Abu Dhabi Launch

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

FREELANDER 8 Makes First Public Appearance Ahead of Official Abu Dhabi Launch

Defiance ETFs Announces Temporary Trading Halt of the Defiance Daily 2X Space ETF (SPCL) on Cboe BZX Exchange, Inc.

HASA Inc. Acquires Swimming Pool Chemicals Manufacturer Bio-Dex Laboratories, Inc.

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us